LivaNova PLC

LIVN ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.39B $1.25B $1.15B $1.02B $1.03B $934.0M $1.08B $1.08B
Neuromodulation $618.3M $545.9M $491.5M $403.2M $472.9M $443.3M
Cardiovascular $530.1M $475.6M $542.4M $530.0M $610.7M $633.4M
CRM $0 $0 $0 $0 $0 $0
Other $1.2M $800.0K $1.0M $800.0K $600.0K $800.0K
Cost of Revenue $448.2M $400.0M $397.7M $314.6M $329.4M $339.5M $360.4M $361.3M
Gross Profit $939.9M $853.5M $755.8M $707.2M $706.0M $594.8M $723.8M $716.2M
Gross Margin 67.7% 68.1% 65.7% 69.2% 68.2% 63.7% 66.8% 66.5%
Operating Expenses
Research & Development $185.8M $182.5M $193.8M $155.8M $183.4M $152.9M $146.8M $145.9M
SG&A Expense $548.8M $508.9M $502.7M $469.2M $471.9M $446.6M $528.5M $465.0M
Operating Income $199.4M $129.1M $-68.5M $-76.8M $-784.0K $-273.9M $-171.6M $-248.1M
Operating Margin 14.4% 10.3% -6.0% -7.5% -0.1% -29.3% -15.8% -23.0%
Interest Expense $58.9M $48.3M $50.2M $40.8M $15.1M $9.8M
Pretax Income $-220.8M $88.3M $-81.2M $-75.1M $-124.5M $-348.0M $-188.4M $-247.4M
Income Tax Expense $21.6M $25.1M $-98.9M $11.1M $11.2M $-960.0K $-30.4M $-69.6M
Net Income $-242.5M $63.2M $17.5M $-86.2M $-135.8M $-348.8M $-157.6M $-189.4M
Net Margin -17.5% 5.0% 1.5% -8.4% -13.1% -37.3% -14.5% -17.6%
EPS (Basic) $-4.45 $1.17 $0.33 $-1.61 $-2.68 $-7.18 $-3.21 $-3.91
EPS (Diluted) $-4.45 $1.16 $0.32 $-1.61 $-2.68 $-7.18 $-3.26 $-3.91
Shares Outstanding (Basic) 54.5M 54.2M 53.9M 53.5M 50.6M 48.6M 48.3M 48.5M
Shares Outstanding (Diluted) 54.5M 54.6M 54.2M 53.5M 50.6M 48.6M 48.3M 48.5M
Dividends Per Share
← Newer Page 1 of 3 Older →